Eleni Kandaraki

3.2k total citations
61 papers, 2.1k citations indexed

About

Eleni Kandaraki is a scholar working on Reproductive Medicine, Public Health, Environmental and Occupational Health and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Eleni Kandaraki has authored 61 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Reproductive Medicine, 20 papers in Public Health, Environmental and Occupational Health and 17 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Eleni Kandaraki's work include Ovarian function and disorders (37 papers), Reproductive Biology and Fertility (19 papers) and Birth, Development, and Health (7 papers). Eleni Kandaraki is often cited by papers focused on Ovarian function and disorders (37 papers), Reproductive Biology and Fertility (19 papers) and Birth, Development, and Health (7 papers). Eleni Kandaraki collaborates with scholars based in Greece, United States and United Kingdom. Eleni Kandaraki's co-authors include Evanthia Diamanti‐Kandarakis, Dimitrios Panidis, Charikleia Christakou, Ilias Katsikis, Frangiskos Economou, Michael Koutsilieris, Olga Papalou, Athanasios G. Papavassiliou, Antonios Chatzigeorgiou and Eleni Palioura and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Endocrinology.

In The Last Decade

Eleni Kandaraki

60 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eleni Kandaraki Greece 25 1.1k 741 451 310 245 61 2.1k
Marta Díaz Spain 29 437 0.4× 473 0.6× 410 0.9× 138 0.4× 555 2.3× 91 2.3k
Małgorzata Szczuko Poland 23 363 0.3× 284 0.4× 143 0.3× 28 0.1× 406 1.7× 115 1.6k
Tevfik Sabuncu Türkiye 22 308 0.3× 254 0.3× 672 1.5× 21 0.1× 192 0.8× 73 1.7k
Yusuf Özlem İlbey Türkiye 18 219 0.2× 155 0.2× 84 0.2× 46 0.1× 207 0.8× 94 1.4k
Mustafa Çekmen Türkiye 21 189 0.2× 207 0.3× 66 0.1× 44 0.1× 290 1.2× 58 1.5k
Giovanni Faccini Italy 25 49 0.0× 196 0.3× 242 0.5× 174 0.6× 253 1.0× 50 2.0k
Chun-Sen Hsu Taiwan 17 331 0.3× 228 0.3× 104 0.2× 43 0.1× 122 0.5× 32 711
Ayşe Eken Türkiye 21 280 0.3× 263 0.4× 83 0.2× 207 0.7× 339 1.4× 65 1.4k
Lawrence M. Resnick United States 30 59 0.1× 312 0.4× 590 1.3× 35 0.1× 327 1.3× 68 2.7k
Abdülmuttalip Şimşek Türkiye 19 149 0.1× 160 0.2× 105 0.2× 38 0.1× 194 0.8× 110 1.5k

Countries citing papers authored by Eleni Kandaraki

Since Specialization
Citations

This map shows the geographic impact of Eleni Kandaraki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eleni Kandaraki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eleni Kandaraki more than expected).

Fields of papers citing papers by Eleni Kandaraki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eleni Kandaraki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eleni Kandaraki. The network helps show where Eleni Kandaraki may publish in the future.

Co-authorship network of co-authors of Eleni Kandaraki

This figure shows the co-authorship network connecting the top 25 collaborators of Eleni Kandaraki. A scholar is included among the top collaborators of Eleni Kandaraki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eleni Kandaraki. Eleni Kandaraki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alexandraki, Krystallenia, et al.. (2021). Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome. touchREVIEWS in Endocrinology. 1(1). 37–37. 1 indexed citations
2.
Alexandraki, Krystallenia, Eleni Kandaraki, Theo Papaioannou, et al.. (2020). Assessment Of Aortic Wave Reflection In Lean And Obese Women With Polycystic Ovary Syndrome. SHILAP Revista de lepidopterología. 55(2). 224–232. 1 indexed citations
4.
Merhi, Zaher, Eleni Kandaraki, & Evanthia Diamanti‐Kandarakis. (2019). Implications and Future Perspectives of AGEs in PCOS Pathophysiology. Trends in Endocrinology and Metabolism. 30(3). 150–162. 49 indexed citations
5.
Papadakis, Georgios, et al.. (2019). Polycystic Ovary Syndrome and NC-CAH: Distinct Characteristics and Common Findings. A Systematic Review. Frontiers in Endocrinology. 10. 388–388. 48 indexed citations
6.
Karras, Spyridon Ν., Stavroula Α. Paschou, Eleni Kandaraki, et al.. (2016). Hypovitaminosis D in pregnancy in the Mediterranean region: a systematic review. European Journal of Clinical Nutrition. 70(9). 979–986. 80 indexed citations
7.
Palioura, Eleni, Sotiria Palimeri, Christina Piperi, et al.. (2015). Impact of Androgen and Dietary Advanced Glycation End Products on Female Rat Liver. Cellular Physiology and Biochemistry. 37(3). 1134–1146. 10 indexed citations
8.
Karras, Spyridon Ν., Panagiotis Anagnostis, Stavroula Α. Paschou, Eleni Kandaraki, & Dimitrios G. Goulis. (2015). Vitamin D status during pregnancy: time for a more unified approach beyond borders?. European Journal of Clinical Nutrition. 69(8). 874–877. 14 indexed citations
9.
Palioura, Eleni, Eleni Kandaraki, & Evanthia Diamanti‐Kandarakis. (2014). Endocrine disruptors and polycystic ovary syndrome: a focus on Bisphenol A and its potential pathophysiological aspects. Hormone Molecular Biology and Clinical Investigation. 17(3). 137–144. 12 indexed citations
10.
Τζιόμαλος, Κωνσταντίνος, et al.. (2013). Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome. Human Reproduction. 28(3). 785–793. 19 indexed citations
11.
Piperi, Christina, Efstathia Papageorgiou, Eleni Kandaraki, Michael Koutsilieris, & Evanthia Diamanti‐Kandarakis. (2013). Advanced glycation end-products inhibit insulin signaling in human granulosa cells. Endocrine Abstracts. 3 indexed citations
12.
Panidis, Dimitrios, Κωνσταντίνος Τζιόμαλος, Efstathios Papadakis, Eleni Kandaraki, & Ilias Katsikis. (2013). The guidelines issued by the European Society for Human Reproduction and Embryology and the American Society for Reproductive Medicine regarding the induction of ovulation with metformin in patients with the polycystic ovary syndrome potentially require reconsideration. HORMONES. 12(2). 192–200. 8 indexed citations
13.
Panidis, Dimitrios, Κωνσταντίνος Τζιόμαλος, Efstathios Papadakis, et al.. (2013). The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome. Clinical Endocrinology. 80(3). 432–438. 32 indexed citations
14.
Panidis, Dimitrios, Κωνσταντίνος Τζιόμαλος, Efstathios Papadakis, et al.. (2012). Association between menstrual cycle irregularities and endocrine and metabolic characteristics of the polycystic ovary syndrome. European Journal of Endocrinology. 168(2). 145–152. 30 indexed citations
15.
Τζιόμαλος, Κωνσταντίνος, Ilias Katsikis, Eleni Kandaraki, et al.. (2011). Weight loss significantly reduces serum lipocalin-2 levels in overweight and obese women with polycystic ovary syndrome. Gynecological Endocrinology. 28(1). 20–24. 26 indexed citations
16.
Panidis, Dimitrios, Κωνσταντίνος Τζιόμαλος, Eleni Kandaraki, et al.. (2010). The effects of obesity and polycystic ovary syndrome on serum lipocalin-2 levels: a cross-sectional study. Reproductive Biology and Endocrinology. 8(1). 151–151. 24 indexed citations
17.
Kandaraki, Eleni, Antonios Chatzigeorgiou, Sarantis Livadas, et al.. (2010). Endocrine Disruptors and Polycystic Ovary Syndrome (PCOS): Elevated Serum Levels of Bisphenol A in Women with PCOS. The Journal of Clinical Endocrinology & Metabolism. 96(3). E480–E484. 284 indexed citations
18.
Economou, Frangiskos, Sarantis Livadas, Ioannis P. Androulakis, et al.. (2009). In overweight/obese but not in normal-weight women, polycystic ovary syndrome is associated with elevated liver enzymes compared to controls. HORMONES. 8(3). 199–206. 45 indexed citations
19.
Diamanti‐Kandarakis, Evanthia, Eleni Kandaraki, Charikleia Christakou, & Dimitrios Panidis. (2009). The effect of pharmaceutical intervention on lipid profile in polycystic ovary syndrome. Obesity Reviews. 10(4). 431–441. 21 indexed citations
20.
Diamanti‐Kandarakis, Evanthia, Ilias Katsikis, Christina Piperi, et al.. (2008). Increased serum advanced glycation end‐products is a distinct finding in lean women with polycystic ovary syndrome (PCOS). Clinical Endocrinology. 69(4). 634–641. 142 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026